A Study to Compare 2 Formulations of LY900014 in Healthy Participants
NCT03334448
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LY900014-U200
DRUG:
LY900014-U100
Sponsor
Eli Lilly and Company